Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3 - Quiz - MDSpire

Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3

  • By

  • Elizabeth Adamowicz

  • Colleen S Kraft

  • Tonya Ward

  • Nirja Mehta

  • William D Shannon

  • Rohan Mishra

  • Ken F Blount

  • July 2, 2025

  • 0 min

Share

Original Source(s)

Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3

  • by Elizabeth Adamowicz, Colleen S Kraft, Tonya Ward, Nirja Mehta, William D Shannon, Rohan Mishra, Ken F Blount

  • July 2, 2025

Related Content

Inflammation Tied to Organ Failure Risk

Review outlines mechanisms, prognosis, and supportive care strategies in surgical and trauma ICU populations

Metabolic and Diagnostic Perspectives on Secondary Lactose Intolerance in Infants Through Fecal Lactose Measurement and Gut Microbiome Analysis

Ankylosing spondylitis and the gut microbiome: future research hotspots and trends